(Q37007590)

English

A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors

scientific article published on September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

1 reference

based on heuristic

inferred from title

author name string

Jeffrey S Weber

1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Nicholas J Vogelzang

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Marc S Ernstoff

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Oscar B Goodman

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Lee D Cranmer

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

John L Marshall

6

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sabrina Miles

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Dar Rosario

8

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

David C Diamond

9

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Zhiyong Qiu

10

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Mihail Obrocea

11

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Adrian Bot

12

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

publication date

1 September 2011

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Journal of Immunotherapy

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

34

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

556-567

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Current status of immunological therapies for prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

29 September 2017

A year of successful cancer vaccines points to a path forward

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

29 September 2017

Characterization of preexisting MAGE-A3-specific CD4+ T cells in cancer patients and healthy individuals and their activation by protein vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

29 September 2017

The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

29 September 2017

Immunotherapeutic strategies in kidney cancer--when TKIs are not enough

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

29 September 2017

Targeted therapies for prostate cancer against the prostate specific membrane antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

29 September 2017

Prostate-specific membrane antigen associates with anaphase-promoting complex and induces chromosomal instability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

29 September 2017

Phase 1 trial of intranodal injection of a Melan-A/MART-1 DNA plasmid vaccine in patients with stage IV melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

29 September 2017

Clinical trials of cancer therapies targeting prostate-specific membrane antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

29 September 2017

Indium-111 capromab pendetide in the management of recurrent prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

29 September 2017

Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

29 September 2017

A comparison and critical analysis of preclinical anticancer vaccination strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

29 September 2017

Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

29 September 2017

The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

29 September 2017

Targeting novel antigens for prostate cancer treatment: focus on prostate-specific membrane antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

29 September 2017

Is prostate-specific membrane antigen a multifunctional protein?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

29 September 2017

Shedding light on immunotherapy for cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

29 September 2017

Preferentially expressed antigen of melanoma (PRAME) in the development of diagnostic and therapeutic methods for hematological malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

29 September 2017

Intralymphatic immunization enhances DNA vaccination.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

29 September 2017

Melanoma vaccines: the paradox of T cell activation without clinical response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

29 September 2017

The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

29 September 2017

Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

29 September 2017

Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

27 June 2018

DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

27 June 2018

Intra-lymph node prime-boost vaccination against Melan A and tyrosinase for the treatment of metastatic melanoma: results of a phase 1 clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

4 September 2018

Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

4 September 2018

Detection and functional analysis of CD8+ T cells specific for PRAME: a target for T-cell therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

4 September 2018

Direct intralymphatic injection of peptide vaccines enhances immunogenicity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

4 September 2018

Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

4 September 2018

Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3709852

4 September 2018

Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21760528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy in renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21760528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multivalent immunity targeting tumor-associated antigens by intra-lymph node DNA-prime, peptide-boost vaccination

1 reference

https://pubmed.ncbi.nlm.nih.gov/21760528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21760528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recognition of prostate tumor cells by cytotoxic T lymphocytes specific for prostate-specific membrane antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/21760528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional dissociation between local and systemic immune response during anti-melanoma peptide vaccination

1 reference

https://pubmed.ncbi.nlm.nih.gov/21760528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Humoral immune response in prostate cancer patients after immunization with gene-based vaccines that encode for a protein that is proteasomally degraded

1 reference

https://pubmed.ncbi.nlm.nih.gov/21760528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Using benchmarks based on historical survival rates for screening new therapies for stage IV melanoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21760528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is everything known in all faces of iceberg in PRAME?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21760528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer immunotherapy targeting tumour-specific antigens: towards a new therapy for minimal residual disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21760528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/CJI.0B013E3182280DB1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37007590&oldid=2098834789"